AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 105 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $548,000 | +0.4% | 14,465 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $546,000 | +109.2% | 14,465 | -2.3% | 0.01% | +100.0% |
| Q2 2016 | $261,000 | +45.0% | 14,809 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $180,000 | -78.9% | 14,809 | -57.7% | 0.00% | -75.0% |
| Q4 2015 | $853,000 | +16.5% | 35,013 | -15.2% | 0.01% | +20.0% |
| Q3 2015 | $732,000 | +0.4% | 41,290 | 0.0% | 0.01% | +25.0% |
| Q2 2015 | $729,000 | -39.5% | 41,290 | +7.4% | 0.01% | -38.5% |
| Q1 2015 | $1,205,000 | -46.2% | 38,441 | -49.9% | 0.01% | -43.5% |
| Q4 2014 | $2,241,000 | +17.3% | 76,787 | -16.8% | 0.02% | +15.0% |
| Q3 2014 | $1,910,000 | -15.9% | 92,326 | +0.7% | 0.02% | -9.1% |
| Q2 2014 | $2,270,000 | +13.7% | 91,647 | -2.7% | 0.02% | +15.8% |
| Q1 2014 | $1,996,000 | -36.5% | 94,188 | -46.2% | 0.02% | -38.7% |
| Q4 2013 | $3,143,000 | – | 175,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |